203 related articles for article (PubMed ID: 38337127)
1. Autoimmune, Autoinflammatory Disease and Cutaneous Malignancy Associations with Hidradenitis Suppurativa: A Cross-Sectional Study.
Brydges HT; Onuh OC; Friedman R; Barrett J; Betensky RA; Lu CP; Caplan AS; Alavi A; Chiu ES
Am J Clin Dermatol; 2024 May; 25(3):473-484. PubMed ID: 38337127
[TBL] [Abstract][Full Text] [Related]
2. Overall and subgroup prevalence of pyoderma gangrenosum among patients with hidradenitis suppurativa: A population-based analysis in the United States.
Tannenbaum R; Strunk A; Garg A
J Am Acad Dermatol; 2019 Jun; 80(6):1533-1537. PubMed ID: 30738122
[TBL] [Abstract][Full Text] [Related]
3. Diseases associated with hidranitis suppurativa: part 2 of a series on hidradenitis.
Scheinfeld N
Dermatol Online J; 2013 Jun; 19(6):18558. PubMed ID: 24011308
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and comorbidities associated with hidradenitis suppurativa in Korea: a nationwide population-based study.
Lee JH; Kwon HS; Jung HM; Kim GM; Bae JM
J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1784-1790. PubMed ID: 29761904
[TBL] [Abstract][Full Text] [Related]
5. Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations.
Garg A; Malviya N; Strunk A; Wright S; Alavi A; Alhusayen R; Alikhan A; Daveluy SD; Delorme I; Goldfarb N; Gulliver W; Hamzavi I; Jaleel T; Kimball AB; Kirby JS; Kirchhof MG; Lester J; Lev-Tov H; Lowes MA; Micheletti R; Orenstein LA; Piguet V; Sayed C; Tan J; Naik HB
J Am Acad Dermatol; 2022 May; 86(5):1092-1101. PubMed ID: 33493574
[TBL] [Abstract][Full Text] [Related]
6. Spectrum of diseases associated with pyoderma gangrenosum and correlation with effectiveness of therapy: New insights on the diagnosis and therapy of comorbid hidradenitis suppurativa.
Fischer AH; Jourabchi N; Khalifian S; Lazarus GS
Wound Repair Regen; 2022 May; 30(3):338-344. PubMed ID: 35385180
[TBL] [Abstract][Full Text] [Related]
7. Overall and subgroup prevalence of acne vulgaris among patients with hidradenitis suppurativa.
Wertenteil S; Strunk A; Garg A
J Am Acad Dermatol; 2019 May; 80(5):1308-1313. PubMed ID: 30287328
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of type 2 diabetes mellitus among patients with hidradenitis suppurativa in the United States.
Garg A; Birabaharan M; Strunk A
J Am Acad Dermatol; 2018 Jul; 79(1):71-76. PubMed ID: 29339240
[TBL] [Abstract][Full Text] [Related]
9. Autoinflammatory syndromes associated with hidradenitis suppurativa and/or acne.
Vinkel C; Thomsen SF
Int J Dermatol; 2017 Aug; 56(8):811-818. PubMed ID: 28345207
[TBL] [Abstract][Full Text] [Related]
10. Genetic mutations in pyoderma gangrenosum, hidradenitis suppurativa, and associated autoinflammatory syndromes: Insights into pathogenic mechanisms and shared pathways.
Satoh TK
J Dermatol; 2024 Feb; 51(2):160-171. PubMed ID: 38031879
[TBL] [Abstract][Full Text] [Related]
11. Risk of psoriasis in people with hidradenitis suppurativa: A systematic review and meta-analysis.
Gau SY; Preclaro IAC; Wei JC; Lee CY; Kuan YH; Hsiao YP; Juang SE; Ma KS
Front Immunol; 2022; 13():1033844. PubMed ID: 36532043
[TBL] [Abstract][Full Text] [Related]
12. Coprevalence of Hidradenitis Suppurativa and Psoriasis: Detailed Demographic, Disease Severity and Comorbidity Pattern.
Pinter A; Sarlak M; Zeiner KN; Malisiewicz B; Kaufmann R; Romanelli M; Koenig A; Chiricozzi A
Dermatology; 2021; 237(5):759-768. PubMed ID: 33326954
[TBL] [Abstract][Full Text] [Related]
13. Opioid, alcohol, and cannabis misuse among patients with hidradenitis suppurativa: A population-based analysis in the United States.
Garg A; Papagermanos V; Midura M; Strunk A; Merson J
J Am Acad Dermatol; 2018 Sep; 79(3):495-500.e1. PubMed ID: 29499293
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous squamous cell carcinoma complicating hidradenitis suppurativa: a review of the prevalence, pathogenesis, and treatment of this dreaded complication.
Chapman S; Delgadillo D; Barber C; Khachemoune A
Acta Dermatovenerol Alp Pannonica Adriat; 2018 Mar; 27(1):25-28. PubMed ID: 29589641
[TBL] [Abstract][Full Text] [Related]
15. Hidradenitis Suppurativa Is Associated with Polycystic Ovary Syndrome: A Population-Based Analysis in the United States.
Garg A; Neuren E; Strunk A
J Invest Dermatol; 2018 Jun; 138(6):1288-1292. PubMed ID: 29378201
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of hidradenitis suppurativa among patients with Down syndrome: a population-based cross-sectional analysis.
Garg A; Strunk A; Midura M; Papagermanos V; Pomerantz H
Br J Dermatol; 2018 Mar; 178(3):697-703. PubMed ID: 28662304
[TBL] [Abstract][Full Text] [Related]
17. Hidradenitis Suppurativa: Estimated Prevalence, Clinical Features, Concomitant Conditions, and Diagnostic Delay in a University Teaching Hospital in Buenos Aires, Argentina.
Zimman S; Comparatore MV; Vulcano AF; Absi ML; Mazzuoccolo LD
Actas Dermosifiliogr (Engl Ed); 2019 May; 110(4):297-302. PubMed ID: 30885385
[TBL] [Abstract][Full Text] [Related]
18. Hidradenitis Suppurativa in Sweden: A Registry-Based Cross-Sectional Study of 13,538 Patients.
Killasli H; Sartorius K; Emtestam L; Svensson Å
Dermatology; 2020; 236(4):281-288. PubMed ID: 32015234
[TBL] [Abstract][Full Text] [Related]
19. Overall and Subgroup Prevalence of Crohn Disease Among Patients With Hidradenitis Suppurativa: A Population-Based Analysis in the United States.
Garg A; Hundal J; Strunk A
JAMA Dermatol; 2018 Jul; 154(7):814-818. PubMed ID: 29800049
[TBL] [Abstract][Full Text] [Related]
20. Hidradenitis Suppurativa-Related Autoinflammatory Syndromes: An Updated Review on the Clinics, Genetics, and Treatment of Pyoderma gangrenosum, Acne and Suppurative Hidradenitis (PASH), Pyogenic Arthritis, Pyoderma gangrenosum, Acne and Suppurative Hidradenitis (PAPASH), Synovitis, Acne, Pustulosis, Hyperostosis and Osteitis (SAPHO), and Rarer Forms.
Maronese CA; Moltrasio C; Marzano AV
Dermatol Clin; 2024 Apr; 42(2):247-265. PubMed ID: 38423685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
